Product NDC: | 63739-464 |
Proprietary Name: | Furosemide |
Non Proprietary Name: | furosemide |
Active Ingredient(s): | 20 mg/2mL & nbsp; furosemide |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63739-464 |
Labeler Name: | McKesson Packaging Services Business unit of McKesson Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018579 |
Marketing Category: | NDA |
Start Marketing Date: | 20100201 |
Package NDC: | 63739-464-05 |
Package Description: | 5 BAG in 1 BOX (63739-464-05) > 1 VIAL, SINGLE-DOSE in 1 BAG > 4 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 63739-464-05 |
Proprietary Name | Furosemide |
Package Description | 5 BAG in 1 BOX (63739-464-05) > 1 VIAL, SINGLE-DOSE in 1 BAG > 4 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 63739-464 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | furosemide |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20100201 |
Marketing Category Name | NDA |
Labeler Name | McKesson Packaging Services Business unit of McKesson Corporation |
Substance Name | FUROSEMIDE |
Strength Number | 20 |
Strength Unit | mg/2mL |
Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |